10-Q: Priority Technology Holdings' Officer Implements Rule 10b5-1 Sales Plan with J.P. Morgan Securities

Sean Kiewiet, Chief Strategy Officer of Priority Technology Holdings, establishes a Rule 10b5-1 sales plan to diversify investments and reduce risk of over concentration.

Summary

• Sean Kiewiet, an officer at Priority Technology Holdings, has adopted a sales plan under Rule 10b5-1 with J.P. Morgan Securities LLC.
• The plan aims to diversify investments and reduce the risk of over-concentration in a particular investment.
• Under the sales plan, JPMS will sell common shares of Priority Technology Holdings (PRTH) on the Nasdaq Capital Market.
• The total amount of shares to be sold is set forth in Schedule A, with JPMS handling the orders on a best-efforts basis.
• The sales will commence on the Sales Commencement Date, defined in Schedule A, and terminate on the Sales End Date, or when all shares are sold.
• JPMS will deduct its reasonable and customary commissions from the proceeds of the sales.
• The plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act.
• Kiewiet confirms he isn't aware of any material, nonpublic information about Priority Technology Holdings and is entering the plan in good faith.
• Kiewiet will not enter into any corresponding or hedging transactions with respect to the shares.
• JPMS will notify both the Issuer and the Seller via email of each transaction pursuant to this Sales Plan no later than one Trading Day after the trading date of such transaction.
• The agreement includes indemnification clauses and limitations on liability for JPMS.
• The plan may be suspended or terminated by Issuer at any time upon one Trading Day prior written notice or terminated by Seller at any time upon one Trading Day prior written notice.
• The plan is governed by the laws of the State of New York.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment. It outlines a structured sales plan, which is a common financial practice. There are no explicit positive or negative statements about the company's performance or future prospects.

Positives

• The sales plan allows for diversification of investments and reduces the risk of over-concentration.
• The plan is structured to comply with Rule 10b5-1, providing a legal framework for insider sales.
• JPMS will attempt to minimize the negative price impact on the market and to attempt to maximize the prices obtained for the shares sold.
• The agreement includes indemnification clauses and limitations on liability for JPMS.

Negatives

• There is no assurance that orders will be executed in whole or in part, especially if limit prices are away from prevailing market prices.
• JPMS may effect sales of Stock which may coincide with sales of Stock by other accounts held with JPMS including, but not limited to, sales made pursuant to other sales plans with JPMS.
• JPMS may not be able to effect a sale due to a market disruption or a legal, regulatory or contractual restriction applicable to JPMS, an insufficient number of shares of Stock being in the Account, JPMS having received written confirmation from the Issuer that the Issuer has not complied with the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 (the Exchange Act) that are a condition to complying with Rule 144 or 145 under the Securities Act, or a pending sale under this Sales Plan causing Seller to exceed any applicable volume limitations of Rule 144 or 145 under the Securities Act.

Risks

• The sales plan's success depends on market conditions and JPMS's ability to execute trades effectively.
• Legal, regulatory, or contractual restrictions could prevent JPMS from executing sales.
• Seller could be impacted by any expense or loss which JPMS may sustain relating to such borrowing or purchase, including any expense or loss JPMS may sustain as a result of its inability to borrow or purchase shares of Stock to complete its delivery obligation.
• The plan could be suspended or terminated under certain circumstances, such as a merger or acquisition, or the death or mental incapacity of the seller.

Future Outlook

The sales plan is set to run until August 31, 2026, or until all shares are sold, subject to market conditions and regulatory constraints.

Industry Context

Rule 10b5-1 plans are commonly used by corporate insiders to sell company stock while avoiding accusations of trading on non-public information. This plan allows Kiewiet to systematically sell shares over time.

Stakeholder Impact

• The sales plan could put downward pressure on the stock price, potentially impacting shareholders.
• The plan provides liquidity for Kiewiet's holdings, benefiting him personally.
• The company's reputation could be affected depending on how the sales are perceived by the market.

Next Steps

• JPMS will begin executing trades on the Sales Commencement Date.
• JPMS will provide trade confirmations and email notifications of transactions.
• JPMS will recalculate the volume limitations on a weekly basis and carry over any unsold shares to be sold in whole or in increments pursuant to the terms of Schedule A as and when the volume limitations permit.

Key Dates

Keywords

Rule 10b5-1, sales plan, Sean Kiewiet, J.P. Morgan Securities, Priority Technology Holdings, stock sales, insider trading, diversification, investments